Chief Executive Officer
Ash Attia has over 30 years of senior executive management experience in implantable devices and biotechnology. Prior to BVT, Ash held the position of Vice President Asia Pacific, the Middle East and Israel, at TransMedics Inc. Ash also held Vice President and Managing Director roles within several other major Australian and International medtech organizations such as Thoratec, St Jude Medical, Micromed, Syncardia, Ventracor, Biotronik, SulzerMedica and Telectronics. Ash has extensive experience in medical technology commercialization, general management, research and development, marketing, market entry strategies, regulatory and reimbursement across multiple geographies (USA, Asia Pacific and Europe). He is also a Fellow of the Australian Institute of Company Directors and has extensive governance experience being a Non-Executive Director on the board of ASX-listed Company DorsaVi for over 10 years. Ash holds a Masters of Science in Biomedical and Electronics Engineering from the New Jersey Institute of Technology in conjunction with the University of Medicine and Dentistry, New Jersey, USA. Ash also holds postgraduate qualifications in business and general management.
BSc (E.Eng/Med Eng with Honors)
MSc (Med. Eng)